Keyword: drug prices

News

US Merck CEO Quits Trump’s Council

16.08.2017 - Kenneth Frazier, CEO of Merck & Co, the third largest US pharmaceutical manufacturer, has resigned from US President Donald Trump’s manufacturing council after criticizing what he...

News

Pharma Stocks Crash on Trump Pricing Hints

13.01.2017 - American drugmakers, who had hoped US President-Elect Donald Trump would go easier on the industry than Hillary Clinton and Bernie Sanders had promised to do, received an...

News

Pfizer Fined Record Sum for UK Overpricing

08.12.2016 - US pharmaceutical major Pfizer has been fined a record £84.2 million by the UK’s competition authority for overcharging the National Health Service (NHS) for an anti-epilepsy drug...

News

High Drug Prices Said Pressuring US Medicare

26.07.2016 - Drugmakers who supply Medicare, the US health insurance for the elderly, are raking in billions of dollars for “pricey medications” at taxpayer expense, a report by the news agency...

News

Valeant CEO Agrees to Senate Deposition

14.04.2016 - Michael Pearson, the controversial CEO of Valeant Pharmaceuticals has bowed to pressure and agreed to be deposed by the US Senate’s Special Committee on Aging, which is...

News

Valeant CEO Asked to Cooperate With US Senate

13.04.2016 - The US Senate’s Special Committee on Aging plans to decide on Apr. 13 whether or not to open contempt proceedings against Valeant Pharmaceuticals CEO Michael Pearson. Pearson, who...

News

Drugmakers Face More Scrutiny of Discordant U.S. Prices

11.05.2013 - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer and...

News

South Africa Seeks to Close Drug Patent Loophole

22.04.2013 - South Africa plans to overhaul its intellectual property laws to improve access to cheaper medicines by making it harder for pharmaceutical firms to register and roll-over patents...